Clinical trial
The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure
NCT00241098 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00241098 |
|---|---|
| Title | The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure |
| Official title | A Randomized, Double Blind, Parallel Group Study to Evaluate the Effects of Valsartan Versus Placebo in Patients With Early Stage Heart Failure Due to Diastolic Dysfunction Already Evidenced by an Elevated B-type Natriuretic Peptide Level: the VALIDATE Study |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | valsartan |
| Enrollment | 37 |
| Start date | May 1, 2003 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Oct 18, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: